RebrAIn
PrivateLast Round
Seed
Mar 18, 2024
Total Funding Raised
$4.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RebrAIn operates in Healthcare & Life Sciences and is based in Pessac. Its latest recorded funding round was a Seed round in March 2024.
RebrAIn is a medical technology company that provides AI-driven precise targeting technology to assist neurosurgeons in surgical treatments for neurodegenerative diseases such as Parkinson's disease and essential tremor.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RebrAIn Comparables
Compare RebrAIn with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MindTrace Technologies Inc. | 79% | |
| Augmedit | 79% | |
| Avatar Medical | 78% |
For institutional investors. Book with your work email.
RebrAIn Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 18, 2024 | ||||
| Pre Seed | Feb 12, 2021 |
For institutional investors. Book with your work email.
RebrAIn Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nouvelle-Aquitaine Co-investissement | Seed |
| Karista | Seed |
| Aquitaine Science Transfert | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 53% MoM.
- Mar 18, 2024
$4M round led by Karista.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 17, 2026
Rebrain is set to take part in WSSFN 2026 in France from Sep 30th to Oct 3rd '26 and hosts a Lunch Symposium on Oct 1st '26.
For institutional investors. Book with your work email.
RebrAIn Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RebrAIn's valuation, stock price, and market status.
Is RebrAIn a public or private company?
RebrAIn is a private company.
What is the current stock price of RebrAIn?
RebrAIn is a private company, so its shares have no public market price. Caplight tracks RebrAIn's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RebrAIn worth (valuation)?
Valuation information for RebrAIn is not publicly available.
Can I buy RebrAIn stock?
RebrAIn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RebrAIn's last funding round?
RebrAIn's most recent funding round was Seed on March 18, 2024.
Who are the main investors in RebrAIn?
Key investors in RebrAIn include Karista.
Will RebrAIn IPO soon?
No public IPO plans have been announced for RebrAIn.
How can I track RebrAIn secondary market activity?
Caplight tracks bids, offers, and trades in RebrAIn's shares on secondary markets.